When did VTRS join the S&P 500?

Viatris joined the S&P 500 index on 2004-04-23.

What sector is VTRS in?

VTRS is in the Health Care sector, Pharmaceuticals industry.

VTRS — Viatris

Name: VTRS Institutional Holdings (13F) — 2026Q1
Creator: SEC EDGAR
License: https://www.sec.gov/data

Pharmaceuticals · Health Care

Viatris Inc. was formed in November 2020 through the merger of Upjohn, Pfizer's wholly-owned subsidiary focused on off-patent medicines, and Mylan, a global pharmaceutical manufacturer focused on generic and specialty medicines. Following the merger, Viatris became one of the world's largest generic drug manufacturers, serving more than 165 countries and regions. Generic medicines (including branded and compounded generics) and biosimilars account for approximately 40% of Viatris' total sales. The remaining 60% of sales come from its legacy portfolio, including Lipitor, Norvasc, Lyrica and Viagra. Viatris spans more than 10 major therapeutic areas and has identified dermatology, ophthalmology and gastroenterology as its three key focus areas for future innovation.

Industry Peers

BMY JNJ LLY MRK PFE ZTS

Sector Peers

A ABBV ABT ALGN AMGN BAX BDX BIIB BMY BSX

Key Facts

Status	Active
Sector	Health Care
Industry	Pharmaceuticals
Joined	2004-04-23
Tenure	22 yrs

S&P 500 Timeline

2004-04-23Joined S&P 500

Institutional Holdings (13F)

1,021 institutions hold VTRS, totaling 1.16B shares ($14.2B) · As of 2026Q1

Rank	Institution	Shares	Value
1	VANGUARD CAPITAL MANAGEMENT LLC	149.4M	$2.0B
2	BlackRock, Inc.	84.4M	$1.1B
3	Davis Selected Advisers	78.2M	$1.1B
4	VANGUARD PORTFOLIO MANAGEMENT LLC	53.9M	$728M
5	STATE STREET CORP	52.2M	$706M
6	MORGAN STANLEY	48.8M	$583M
7	DIMENSIONAL FUND ADVISORS LP	38.3M	$518M
8	Rubric Capital Management LP	33.5M	$453M
9	GEODE CAPITAL MANAGEMENT, LLC	31.8M	$430M
10	BARCLAYS PLC	37.3M	$407M

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10